4.7 Article

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation

Martin Vos et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2018)

Review Transplantation

Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences

Badri Man Shrestha

EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2017)

Article Biotechnology & Applied Microbiology

Current State of Immunosuppression: Past, Present, and Future

Sabine Karam et al.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2015)

Review Pharmacology & Pharmacy

Everolimus and sirolimus in transplantation-related but different

Jost Klawitter et al.

EXPERT OPINION ON DRUG SAFETY (2015)

Review Urology & Nephrology

Role of pharmacogenomics in dialysis and transplantation

Kelly Birdwell

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)

Article Medicine, General & Internal

Modern immunosuppression after solid organ transplantation

J. Beimler et al.

INTERNIST (2014)

Review Surgery

KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

Kai-Uwe Eckardt et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2009)

Article Urology & Nephrology

Trends in adult post-kidney transplant immunosuppressive use in Australia, 1991-2005

Sean H. Chang et al.

NEPHROLOGY (2008)

Article Medicine, General & Internal

Improved graft survival after renal transplantation in the United States, 1988 to 1996.

S Hariharan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)